All the news Showing 10 of 62 articles from: Hepatocellular carcinoma (HCC)Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Nearly one-third of patients with previous HCC recur after DAA therapy Healio Hepatology / 15 April 2016 High alcohol consumption increases risk for HCC in fatty liver disease Healio Hepatology / 20 January 2016 PD-1 checkpoint inhibitor nivolumab shows promise against liver cancer Liz Highleyman / 03 June 2015 Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor nivolumab (Opdivo) demonstrated good safety and anti-tumour activity against hepatocellular carcinoma in a phase 1/2 study presented at the American Society of Clinical Oncology (ASCO) annual meeting this ... People with hepatitis C have higher cancer rates, even when excluding liver cancer Liz Highleyman / 11 May 2015 Hepatitis C patients in the Kaiser Permanente Southern California health maintenance organisation had significantly increased cancer rates compared to members without HCV infection, researchers reported at the European Association for the Study of ... Many hepatitis C patients with cirrhosis or advanced fibrosis face liver failure and liver cancer Liz Highleyman / 07 January 2015 Nearly one-third of chronic hepatitis C patients with liver cirrhosis and 12% with advanced fibrosis progressed to decompensation within five years, and 23% and 11%, respectively, died, according to a study presented ... Drug-loaded beads may help treat liver cancer Eurekalert Medicine & Health / 07 October 2014 Low uptake of HCV treatment in England will lead to substantial disease burden by 2035 Michael Carter / 24 June 2014 Only 3% of people with chronic hepatitis C virus (HCV) are treated for their infection each year in England, according to research published in the Journal of Hepatology. The current uptake of ... Successful hepatitis C treatment reduces risk of liver cancer and death, but most remain untreated Liz Highleyman / 19 November 2013 Hepatitis C treatment that leads to viral cure significantly reduces the likelihood of liver disease progression and liver-related mortality, but most people with hepatitis C remain untreated, according to a presentation at The Liver ... HCC treatment underutilized in the US Healio Hepatology / 02 September 2013 ‘HCC-4 risk score’ IDs hepatitis C patients likely to develop HCC Family Practice News / 01 August 2013 ← Prev1...34567Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds